529.93
price up icon0.56%   +2.97
after-market  After Hours:  529.93 
loading

Elevance Health Inc Stock (ELV) Forecast

The Elevance Health Inc (ELV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $529.99, representing a +0.01% increase from the current price of $529.93. The highest analyst price target is $553.76, and the lowest is $506.21.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELV Price Target
Average 530.88 (+0.18% Upside)
loading

Is Elevance Health Inc (ELV) A Buy Now?

Oscillators
Name Value Action
RSI(14) 58.39 Neutral
STOCH(9,6) 41.00 Neutral
STOCHRSI(14) 37.16 Neutral
MACD(12,26) 5.3567 Sell
ADX(14) 18.74 Neutral
William %R -34.12 Neutral
CCI(14) -1.7163 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
531.35
Sell
527.93
Buy
MA20
522.00
Buy
524.02
Buy
MA50
513.77
Buy
514.54
Buy
MA100
499.32
Buy
502.29
Buy
MA200
479.04
Buy
489.47
Buy
Buy: 9 Sell: 1 Neutral: 0
Summary: Buy
According to our latest analysis, ELV could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on ELV, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 58.39 indicates that ELV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 41 indicates that ELV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 37.16 indicates that ELV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 18.74 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -1.7163 indicates that ELV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term ELV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Elevance Health Inc financial reports and earnings history, Elevance Health Inc (ELV) stock could reach $611.42 by 2030, $819.95 by 2040 and $1,049.29 by 2050. See the projected annual prices until 2050 of the Elevance Health Inc stock below:

  • Elevance Health Inc (ELV) is expected to reach an average price of $716.87 in 2035, with a high prediction of $743.78 and a low estimate of $685.75. This indicates an $35.28% rise from the last recorded price of $529.93.
  • Elevance Health Inc (ELV) stock is projected to chart a bullish course in 2040, with an average price target of $782.89, representing an $47.74% surge from its current level. The forecast ranges from a conservative $766.98 to a sky-high $819.95.
  • Our analysts predict Elevance Health Inc (ELV) to jump 79.22% by 2045, soaring from $928.09 to an average price of $949.73, potentially reaching $952.32. While $928.09 is the low estimate, the potential upside is significant.
  • Elevance Health Inc (ELV) stock is expected to climb by 2050, reaching an average of $1,018.63, a $92.22% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,049.29 and $1,010.80, respectively, highlighting the market's uncertainty.

Elevance Health Inc Stock (ELV) Year by Year Forecast

Elevance Health Inc Stock (ELV) Price Forecast for 2024

Our forecast for ELV stock price in 2024 now indicates an average price target of $519.83 with a high forecast of $590.63 and a low forecast of $449.02. The average prediction reflects an decrease of -1.91% from the last recorded price of $529.93.
Month Average Low High Change from today's price
June, 2024 $524.25 $506.21 $553.76 -1.07%
July, 2024 $494.77 $486.92 $540.25 -6.63%
August, 2024 $552.09 $480.97 $563.32 +4.18%
September, 2024 $532.53 $521.82 $590.63 +0.49%
October, 2024 $566.25 $515.45 $578.38 +6.85%
November, 2024 $516.93 $506.09 $585.37 -2.45%
December, 2024 $541.57 $509.46 $550.36 +2.20%

Elevance Health Inc Stock (ELV) Price Forecast for 2025

Elevance Health Inc Stock (ELV) is expected to reach an average price of $499.85 in 2025, with a high prediction of $545.31 and a low estimate of $454.39. This indicates an -5.68% fall from the last recorded price of $529.93.
Month Average Low High Change from today's price
January, 2025 $511.40 $508.53 $545.31 -3.50%
February, 2025 $498.55 $482.17 $518.80 -5.92%
March, 2025 $492.72 $485.63 $540.35 -7.02%
April, 2025 $488.03 $487.26 $519.22 -7.91%
May, 2025 $485.47 $471.13 $524.32 -8.39%
June, 2025 $481.12 $454.39 $495.86 -9.21%
July, 2025 $516.60 $477.07 $523.37 -2.51%
August, 2025 $485.05 $482.21 $519.11 -8.47%
September, 2025 $478.21 $476.49 $498.67 -9.76%
October, 2025 $493.04 $474.20 $525.39 -6.96%
November, 2025 $521.80 $480.40 $525.27 -1.53%
December, 2025 $509.82 $502.28 $532.20 -3.80%

Elevance Health Inc Stock (ELV) Price Forecast for 2026

The predicted value for Elevance Health Inc (ELV) in 2026 is set at an average of $562.06. Estimates vary from a peak of $631.74 to a trough of $492.37, indicating an +6.06% surge from the present price of $529.93.
Month Average Low High Change from today's price
January, 2026 $507.96 $492.37 $532.02 -4.15%
February, 2026 $549.56 $504.86 $550.30 +3.70%
March, 2026 $542.71 $535.66 $560.18 +2.41%
April, 2026 $551.11 $537.40 $564.91 +4.00%
May, 2026 $572.46 $538.10 $585.92 +8.03%
June, 2026 $540.82 $532.59 $580.55 +2.06%
July, 2026 $565.02 $540.84 $594.53 +6.62%
August, 2026 $562.02 $549.35 $581.11 +6.05%
September, 2026 $593.14 $521.93 $604.37 +11.93%
October, 2026 $573.71 $563.00 $631.74 +8.26%
November, 2026 $606.20 $556.66 $619.68 +14.39%
December, 2026 $558.39 $547.55 $626.73 +5.37%

Elevance Health Inc Stock (ELV) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Elevance Health Inc (ELV) is $544.36, with a high forecast of $591.94 and a low forecast of $496.78. This indicates an +2.72% increase from the last price of $529.93.
Month Average Low High Change from today's price
January, 2027 $583.15 $550.94 $591.94 +10.04%
February, 2027 $561.44 $553.56 $586.92 +5.95%
March, 2027 $540.41 $524.03 $566.43 +1.98%
April, 2027 $534.71 $527.62 $582.30 +0.90%
May, 2027 $542.04 $529.36 $561.26 +2.29%
June, 2027 $527.74 $513.40 $566.55 -0.41%
July, 2027 $523.51 $496.78 $538.16 -1.21%
August, 2027 $548.20 $519.49 $565.79 +3.45%
September, 2027 $527.72 $524.88 $561.69 -0.42%
October, 2027 $521.01 $519.25 $541.43 -1.68%
November, 2027 $527.29 $517.03 $568.27 -0.50%
December, 2027 $564.88 $523.38 $568.35 +6.59%

Elevance Health Inc Stock (ELV) Price Forecast for 2028

In 2028, Elevance Health Inc (ELV) is projected to reach an average price of $604.29, with a high projection of $672.85 and a low estimate of $535.73. This indicates an +14.03% rise from the last price of $529.93.
Month Average Low High Change from today's price
January, 2028 $554.86 $548.95 $575.40 +4.70%
February, 2028 $561.76 $545.51 $575.31 +6.01%
March, 2028 $593.04 $535.73 $593.78 +11.91%
April, 2028 $586.32 $579.27 $603.75 +10.64%
May, 2028 $594.87 $581.16 $608.63 +12.25%
June, 2028 $616.35 $581.89 $629.77 +16.31%
July, 2028 $581.44 $573.21 $621.17 +9.72%
August, 2028 $605.78 $581.48 $635.29 +14.31%
September, 2028 $602.91 $590.24 $621.97 +13.77%
October, 2028 $593.82 $562.88 $606.73 +12.06%
November, 2028 $614.88 $595.31 $672.85 +16.03%
December, 2028 $647.49 $597.86 $660.97 +22.18%

Elevance Health Inc Stock (ELV) Price Forecast for 2029

The 2029 price forecast for Elevance Health Inc Stock (ELV) is $603.63 on average, with a high prediction of $668.09 and a low estimate of $539.16. This represents an +13.91% increase from the previous price of $529.93.
Month Average Low High Change from today's price
January, 2029 $599.84 $589.00 $668.09 +13.19%
February, 2029 $624.72 $592.43 $633.51 +17.89%
March, 2029 $603.14 $595.20 $628.53 +13.81%
April, 2029 $588.65 $576.43 $608.16 +11.08%
May, 2029 $576.69 $565.88 $624.25 +8.82%
June, 2029 $584.15 $571.47 $603.31 +10.23%
July, 2029 $596.87 $565.07 $608.79 +12.63%
August, 2029 $565.89 $539.16 $602.62 +6.79%
September, 2029 $590.72 $561.91 $608.21 +11.47%
October, 2029 $570.38 $567.54 $604.26 +7.63%
November, 2029 $563.80 $562.01 $584.19 +6.39%
December, 2029 $570.21 $559.85 $611.16 +7.60%

Elevance Health Inc Stock (ELV) Price Forecast for 2030

Elevance Health Inc Stock (ELV) is expected to reach an average price of $640.16 in 2030, with a high forecast of $713.96 and a low forecast of $566.36. This signifies an +20.80% surge from the last price of $529.93.
Month Average Low High Change from today's price
January, 2030 $607.95 $566.36 $611.42 +14.72%
February, 2030 $598.05 $592.05 $618.59 +12.86%
March, 2030 $605.09 $588.74 $618.60 +14.18%
April, 2030 $625.46 $579.08 $627.87 +18.03%
May, 2030 $629.92 $616.90 $647.32 +18.87%
June, 2030 $649.72 $627.61 $652.36 +22.61%
July, 2030 $660.23 $624.92 $673.63 +24.59%
August, 2030 $622.05 $613.82 $661.78 +17.38%
September, 2030 $666.49 $622.12 $669.74 +25.77%
October, 2030 $643.80 $631.13 $676.06 +21.49%
November, 2030 $634.84 $603.84 $647.66 +19.80%
December, 2030 $691.23 $636.35 $713.96 +30.44%
healthcare_plans CI
$342.41
price up icon 0.27%
healthcare_plans CVS
$55.97
price up icon 0.13%
healthcare_plans CNC
$75.14
price up icon 0.44%
healthcare_plans HUM
$319.23
price down icon 0.41%
healthcare_plans MOH
$343.21
price up icon 1.04%
Cap:     |  Volume (24h):